Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 191,840 | 174,414 | 170,528 | 186,523 | 191,214 |
| Cost of Goods | 93,194 | 87,924 | 85,277 | 99,875 | 89,273 |
| Gross Profit | 98,646 | 86,490 | 85,251 | 86,648 | 101,941 |
| Operating Expenses | 73,520 | 45,230 | 48,235 | 42,379 | 45,166 |
| Operating Income | 25,320 | 42,184 | 37,293 | 45,144 | 57,048 |
| Interest Expense | 6,284 | 6,281 | 6,286 | 6,425 | 6,698 |
| Other Income | 2,477 | 3,432 | -145 | 5,243 | -2,667 |
| Pre-tax Income | 21,513 | 39,335 | 30,862 | 43,962 | 47,683 |
| Income Tax | 4,163 | 8,305 | 5,577 | 5,998 | 7,254 |
| Net Income Continuous | 17,350 | 31,030 | 25,285 | 37,964 | 40,429 |
| Net Income | $17,350 | $31,030 | $25,285 | $37,964 | $40,429 |
| EPS Basic Total Ops | 0.38 | 0.66 | 0.53 | 0.79 | 0.83 |
| EPS Basic Continuous Ops | 0.37 | 0.66 | 0.53 | 0.79 | 0.83 |
| EPS Diluted Total Ops | 0.37 | 0.64 | 0.51 | 0.74 | 0.78 |
| EPS Diluted Continuous Ops | 0.36 | 0.64 | 0.51 | 0.74 | 0.78 |
| EPS Diluted Before Non-Recurring Items | 0.83 | 0.75 | 0.61 | 0.83 | 0.87 |
| EBITDA(a) | $40,334 | $57,642 | $51,664 | $59,304 | $71,192 |